Bioactive gas-encapsulated echogenic liposomes and methods for treating cardiovascular disease
AssigneeUniversity of Cincinnati
InventorsChristy Holland, Jason Raymond, Jonathan Sutton
Life of this patent
Estimating the term…
Loading patent…
AssigneeUniversity of Cincinnati
InventorsChristy Holland, Jason Raymond, Jonathan Sutton
Estimating the term…
Echogenic liposomes (ELIP) formulated with an at least partially pegylated phospholipid bi-layer shell, encapsulated nitric oxide, and encapsulated perfluorocarbon of the formula CxFy in a ratio of about 1:1 by volume, wherein X is greater than or equal to 3, are disclosed, along with methods for treating a patients suffering from cardiovascular disease by administering the ELIP at a site remote from the target diseased section, monitoring presence of the ELIP at the target diseased section, and administering ultrasound upon detection of presence such that bioactive NO is released at the target diseased section.
A method for treating a patient suffering from cardiovascular disease, the method comprising:
A method of preventing passive diffusion of NO from a liposome into a non-target tissue or fluid, the method comprising encapsulating the NO with a perfluorocarbon of the formula CxFy, wherein X is greater than or equal to three.
An ex vivo method for assessing therapeutic suitability of a liposome comprising NO and a perfluorocarbon in a volume ratio, the method comprising (i) administering the liposome to a segment of vasculature while exposing the section of vasculature to ultrasound;
A method of manufacturing an echogenic liposome effective for ultrasound-mediated drug release, the method comprising:
A method of quantitatively assessing an agent or an amount of an agent for efficacy in ultrasound-mediated drug release, the method comprising providing a viable segment of arterial vasculature mounted in a physiological buffer solution;
An echogenic liposome comprising an at least partially pegylated phospholipid bi-layer shell, encapsulated nitric oxide, and encapsulated perfluorocarbon of the formula CxFy, wherein X is greater than or equal to 3, further wherein the ratio of NO to CxFy is about 1:1 by volume.
Dependencies are inferred from the claim text.